Investor relations

Zealand maintains an active approach to IR in order to provide transparency into our business and our activities. An open and transparent communication is the best way to maintain the confidence of our shareholders, and we achieve this through company announcements, investor meetings, company presentations, our company website and social media.

We are committed to providing reliable and transparent information about our business, development programs and scientific results in a clear and timely manner.

We encourage investors, analysts and other external stakeholders to contact us with any questions or other inquiries relating to Zealand. Please find our IR Policy here.

Information Alerts

Register here to receive news releases directly.

For all shareholders, please register your email address via the Shareholder portal.

Investor Contacts

Anna Krassowska
Vice President, Investor Relations & Corporate Communications
ank@zealandpharma.com

Adam Lange
Investor Relations Officer
akl@zealandpharma.com

Questions for the Investor Relations department can also be emailed to investors@zealandpharma.com